(3,5-Dimethyl-1H-pyrazol-1-yl)(2-methoxypyrimidin-5-yl)methanone

Catalog No. :
ACEGCQ127
CAS No. :
1774900-65-0
Molecular Formula :
C11H12N4O2
Molecular Weight :
232.24

IUPAC Name:(3,5-dimethyl-1H-pyrazol-1-yl)(2-methoxypyrimidin-5-yl)methanone

(3,5-Dimethyl-1H-pyrazol-1-yl)(2-methoxypyrimidin-5-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$337.00Login to see priceInquiryInquiry
1g97%$650.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3,5-Dimethyl-1H-pyrazol-1-yl)(2-methoxypyrimidin-5-yl)methanone
IUPAC Name(3,5-dimethyl-1H-pyrazol-1-yl)(2-methoxypyrimidin-5-yl)methanone
MDL No.MFCD26130052
Molecular FormulaC11H12N4O2
Molecular Weight232.24
SMILESO=C(N1N=C(C)C=C1C)C2=CN=C(OC)N=C2
InChI KeySQHADESFFUADJZ-UHFFFAOYSA-N
Synonym(3,5-Dimethyl-pyrazol-1-yl)-(2-methoxy-pyrimidin-5-yl)-methanone;Methanone, (3,5-dimethyl-1H-pyrazol-1-yl)(2-methoxy-5-pyrimidinyl)-
CAS No.1774900-65-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEGCQ127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVMRT356 route compound structure diagram
    ACVMRT35667-51-6 In Stock
  4. Then
  5. ACEGCQ127 route product structure diagram
    ACEGCQ1271774900-65-0
Inquiry

2. ACEGCQ127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDEMC263 route compound structure diagram
    ACDEMC263344325-95-7 In Stock
  2. Plus
  3. ACVMRT356 route compound structure diagram
    ACVMRT35667-51-6 In Stock
  4. Then
  5. ACEGCQ127 route product structure diagram
    ACEGCQ1271774900-65-0
Inquiry

Comments (0)